Clinical pathways matter for multimodal deep learning in early Alzheimer's disease detection.

Identifying individuals at risk of Alzheimer's disease (AD), particularly in the preclinical and early stages, remains challenging. Although deep learning approaches based on structural MRI show promise as a non-invasive biomarker, existing multimodal models require task-speci...

• Source: Radiology AI literature (PubMed) (AI)
• Type: Research

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.